e-learning
resources
Munich 2006
Tuesday 05.09.2006
Mechanisms of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Extended NO analysis in a healthy subgroup in a random sample population
M. Högman, J. Lafih, K. Bröms, T. Holmkvist, A. Malinovschi, C. Janson, P. Meriläinen (Uppsala, Gavle, Sweden)
Source:
Annual Congress 2006 - Mechanisms of respiratory diseases
Session:
Mechanisms of respiratory diseases
Session type:
Thematic Poster Session
Number:
3798
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Högman, J. Lafih, K. Bröms, T. Holmkvist, A. Malinovschi, C. Janson, P. Meriläinen (Uppsala, Gavle, Sweden). Extended NO analysis in a healthy subgroup in a random sample population. Eur Respir J 2006; 28: Suppl. 50, 3798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Extended NO-measurements in a random sample population
Source: Eur Respir J 2003; 22: Suppl. 45, 448s
Year: 2003
Additional analysis of a longitudinal study at two pooled cohorts of salt miners with mixed model analysis
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Aero-allergen sensitization in a general population: data from the LEAD population cohort study
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Comparison between measured lung function in a healthy elderly women sample and values from predicted equation for general adults
Source: Annual Congress 2010 - New diagnostic approaches in respiratory function
Year: 2010
Analysis of disproportionate stratified subsamples in epidemiological studies
Source: Eur Respir J 2004; 24: Suppl. 48, 266s
Year: 2004
COPD subphenotypes in a population-based survey by factor and cluster analysis
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Data-driven questionnaire based cluster analysis of asthma in Swedish adults.
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Respiratory disease phenotypes in a general population sample: latent transition analysis
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018
Unbiased clinical cluster analysis across a combined European and a Brazilian severe asthma (SA) population.
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018
Multivariate genetic analysis of atopy phenotypes in a selected sample of twins
Source: Eur Respir J 2006; 28: Suppl. 50, 143s
Year: 2006
Phenotyping asthmatic outpatients by cluster analysis in a real-world setting
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
The EvA study: Characteristics of the study population
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012
Longitudinal validation of clinical COPD phenotypes identified by cluster analysis
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Estimates of sample sizes
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Validation of the ILD-GAP model in a Singapore population
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Induced sputum cellularity: effect of age on reference values in a population of healthy subjects
Source: Eur Respir J 2003; 22: Suppl. 45, 257s
Year: 2003
Prediction equations for lung function in healthy, non-smoking Malaysian population
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010
Use of a 'COPD prevalence model' in two Italian general population samples
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
A contemporary survival analysis of individuals with cystic fibrosis: a cohort study
Source: Eur Respir J 2015; 45: 670-679
Year: 2015
Spirometric values in a random population sample and their relation to ERS reference values and COPD criteria
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept